VP
RXST icon

Vitruvian Partners’s RxSight RXST Stock Holding History

Vitruvian Partners’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.34M Hold
278,865
– – 0.67% 8
2026
Q1 		$1.72M Hold
278,865
– – 1.54% 7
2025
Q4 		$2.91M Buy
278,865
+48,122
+21% +$483K 2.09% 7
2025
Q3 		$2.07M Hold
230,743
– – 1.44% 7
2025
Q2 		$3M Hold
230,743
– – 1.83% 7
2025
Q1 		$5.83M Buy
230,743
+86,443
+60% +$2.57M 5.56% 5
2024
Q4 		$4.96M Buy
+144,300
New +$6.51M 4.27% 5

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vitruvian Partners's RXST Position: Q2 2026 in Review

Vitruvian Partners held its RxSight (RXST) position steady in Q2 2026 at 278,865 shares worth $1.34M. The position accounts for 0.67% of the portfolio, ranked #8.

Vitruvian Partners first reported a position in RXST in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.83M in Q1 2025. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Vitruvian Partners held 278,865 shares of RxSight worth $1.34M as of Q2 2026.
  • Vitruvian Partners left its RxSight share count unchanged in Q2 2026.
  • RxSight made up 0.67% of Vitruvian Partners's portfolio in Q2 2026, its #8 holding.
  • Vitruvian Partners first reported a position in RxSight in Q4 2024 and has held it in 7 quarters since.
  • Vitruvian Partners's RxSight position peaked at $5.83M in Q1 2025.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Vitruvian Partners's 13F filing for Q2 2026, filed 10 Aug 2026.